Cargando…
A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects
The aim of this study was to evaluate the tolerability, safety, and pharmacokinetics of single and continuous dose administration of recombinant neorudin (EPR‐hirudin, EH) by intravenous administration in healthy subjects, and to provide a safe dosage range for phase II clinical research. Forty‐four...
Autores principales: | Liu, Yubin, Wang, Meixia, Dong, Xiaona, He, Jia, Zhang, Lin, Zhou, Ying, Xia, Xia, Dou, Guifang, Wu, Chu‐tse, Jin, Jide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101608/ https://www.ncbi.nlm.nih.gov/pubmed/33957018 http://dx.doi.org/10.1002/prp2.785 |
Ejemplares similares
-
The Antithrombotic Effect of Recombinant Neorudin on Thrombi
por: Liu, Yu-Bin, et al.
Publicado: (2022) -
Recombinant Neorudin for the Prevention of Deep-Vein Thrombosis After Spinal-Cord Injury
por: Liu, Yu-Bin, et al.
Publicado: (2023) -
Inhibitory role of recombinant neorudin on canine coronary artery thrombosis
por: Liu, Yu‐bin, et al.
Publicado: (2022) -
Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects
por: Xu, Junyu, et al.
Publicado: (2023) -
Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects
por: Chung, Hyewon, et al.
Publicado: (2023)